Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Zane Mills

Showing results (1-10 of 3) with videos related to

Pageof 1
Sort By:
Medcomm|November 12, 2021
Novel cell sources for bone regenerationChenshuang Li, Zane Mills, Zhong Zheng
Biomaterials|October 22, 2019
Neural EGFL like 1 as a potential pro-chondrogenic, anti-inflammatory dual-functional disease-modifying osteoarthritis drugChenshuang Li, Zhong Zheng, Pin Ha, et al.
The Journal of Clinical Investigation|July 16, 2019
CDKN2B upregulation prevents teratoma formation in multipotent fibromodulin-reprogrammed cellsZhong Zheng, Chenshuang Li, Pin Ha, et al.
Pageof 1

Showing results (1-10 of 3) with videos related to

Sort By:
Pageof 1
Medcomm|November 12, 2021
Novel cell sources for bone regenerationChenshuang Li, Zane Mills, Zhong Zheng
Biomaterials|October 22, 2019
Neural EGFL like 1 as a potential pro-chondrogenic, anti-inflammatory dual-functional disease-modifying osteoarthritis drugChenshuang Li, Zhong Zheng, Pin Ha, et al.
The Journal of Clinical Investigation|July 16, 2019
CDKN2B upregulation prevents teratoma formation in multipotent fibromodulin-reprogrammed cellsZhong Zheng, Chenshuang Li, Pin Ha, et al.
Pageof 1